Breast Cancer News and Research

Latest Breast Cancer News and Research

Biologist investigates CAPV-EAE population for hereditary breast and ovary cancer

Between 5 % and 10 % of breast cancer cases are hereditary, arising because the patient inherits from the father or mother a mutation in a gene that is susceptible to causing the illness. BRCA1 and BRCA2 have already been identified as two of the genes to be monitored. It is estimated that 30 % of hereditary breast cancer cases are due to mutations in one of these two genes.

19 Feb 2011

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

The 2011 Clinical Congress of the American College of Surgeons—one of the largest international meetings of surgeons in the world—will convene October 23-27, 2011, in San Francisco, CA. The San Francisco Hilton will serve as the headquarters hotel for the meeting, and the Moscone Convention Center will house the scientific panel sessions and courses, as well as all scientific and technical exhibits.

19 Feb 2011

Researchers discover new 'driver gene' in oestrogen receptor positive breast cancer

CANCER RESEARCH UK scientists have pinpointed a key cancer-causing gene that, when overactive, triggers a particularly aggressive type of breast cancer to develop.

18 Feb 2011

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Cyclacel Pharmaceuticals, Inc., today announced the publication of preclinical data in the Proceedings of the National Academy of Sciences (PNAS), demonstrating that cyclin E plays a major role in making Human Epidermal growth factor Receptor 2 positive (HER2+) breast cancer resistant to trastuzumab (Herceptin®), a widely used medicine for breast cancer patients who test positive for HER2.

18 Feb 2011

Retired NC judge calls for full compensation on medical malpractice damages

A new bill designed to limit the rights of patients injured by medical malpractice is dangerous because it puts patients at risk, according to a bipartisan group that shared stories and opinions at a public hearing, as well as unconstitutional.

18 Feb 2011

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

DiaGenic has significantly altered its business strategy during 2010 to leverage more effectively its commercial potential, and strengths in Intellectual Property (IP). The Company has made significant progress in its business activities towards big pharma since implementation of the new strategy. DiaGenic is well positioned as a multimodal partner with large pharma and imaging companies.

18 Feb 2011

Viewpoints: Arizona's waiver; next gen's 'different' Medicare?; individual mandate's constitutionality

There may be no federal obstacles to cutting 250,000 people out of AHCCCS, part of Gov. Jan Brewer's budget proposal. But there are compelling reasons to avoid such a drastic step if at all possible. And it's possible.

17 Feb 2011

1000th clinical trial added to Cancer Research UK's patient information website

Cancer Research UK has added the 1000th clinical trial to its award winning patient information website, CancerHelp UK, on the 10th anniversary of the launch of its clinical trials database today.

17 Feb 2011

Study analyses number of mortality rates among Spanish women with breast cancer

Pioneering Spanish provinces in terms of early prevention of breast cancer, such as Navarre and the Basque Country, record lower death rates, although the trend is towards the figures levelling out all over Spain. These are the results of a study carried out by Spanish researchers, which analyses the number of women who died between 1975 and 2005.

17 Feb 2011

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Genomic Health, Inc. today announced the presentation of two studies at the American Society of Clinical Oncology® (ASCO®) Genitourinary (GU) Cancer Symposium, including complete results from its prostate cancer gene identification study, which identified 295 genes strongly associated with clinical recurrence following radical prostatectomy with great consistency across multiple tumor samples examined in each patient.

17 Feb 2011

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Medtronic Inc., today announced the results of the first randomized, controlled trial comparing Kyphon Balloon Kyphoplasty with non-surgical care in treating spinal fractures in cancer patients. The study found that Kyphon Balloon Kyphoplasty provided cancer patients better back-specific function, more rapid back pain relief and improved quality of life compared with non-surgical care one month after treatment.

17 Feb 2011

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

17 Feb 2011

Bone remodeling inflammatory protein linked to metastatic lung cancer development in mice with breast cancer

When doctors discover high concentrations of regulatory T cells in the tumors of breast cancer patients, the prognosis is often grim, though why exactly has long been unclear.

16 Feb 2011

Passion for dancing helps beat breast cancer

When Karen Franklin was diagnosed with breast cancer last year, it was her passion for Zumba® that helped her beat the disease. Franklin's story, say experts at The University of Texas MD Anderson Cancer Center, reminds us about exercise's cancer-fighting benefits.

16 Feb 2011

UT Southwestern treats breast-cancer patient with Accuray CyberKnife System

Breast-cancer patient Kristin Wiginton is the first to be treated at UT Southwestern Medical Center with high-beam radiation using the Accuray CyberKnife System, which offers improved cosmetic results, less radiation exposure to surrounding tissue and a shorter treatment period.

16 Feb 2011

New review: Multiple interventions might enable work-related outcomes among cancer survivors

For cancer survivors who wish to return to work after treatment, a new evidence review suggests that therapies focusing on a wide range of health interventions might best enable them to do so.

16 Feb 2011

CTI's fourth quarter net loss increases to $34.1 million

Cell Therapeutics, Inc. today reported recent accomplishments and financial results for the fourth quarter and year ended December 31, 2010.

16 Feb 2011

Diagnosis of breast cancer in women over 70 leads to lower survival

Women over 70 are being diagnosed with breast cancer at a later stage leading to lower survival from the disease in the elderly, new research showed today (Wednesday).

16 Feb 2011

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.

16 Feb 2011

Study: Overexpression of EZH2 protein promotes breast cancer progression

An essential protein for normal stem cell renewal also promotes the growth of breast cancer stem cells when it's overproduced in those cells, researchers at The University of Texas MD Anderson Cancer Center report in the February edition of Cancer Cell.

16 Feb 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

Biologist investigates CAPV-EAE population for hereditary breast and ovary cancer

2011 Clinical Congress of American College of Surgeons to take place in October, in San Francisco

Researchers discover new 'driver gene' in oestrogen receptor positive breast cancer

Cyclacel's CYC065 CDK inhibitor demonstrates potential against breast cancer resistant to trastuzumab

Retired NC judge calls for full compensation on medical malpractice damages

DiaGenic fourth quarter operating revenue increases to NOK 1,078 thousand

Viewpoints: Arizona's waiver; next gen's 'different' Medicare?; individual mandate's constitutionality

1000th clinical trial added to Cancer Research UK's patient information website

Study analyses number of mortality rates among Spanish women with breast cancer

Genomic Health to present prostate cancer studies at ASCO Genitourinary Cancer Symposium

Medtronic: Kyphon Balloon Kyphoplasty provides better back pain relief in cancer patients

Astellas, AVEO enter development, commercialization agreement for tivozanib

Bone remodeling inflammatory protein linked to metastatic lung cancer development in mice with breast cancer

Passion for dancing helps beat breast cancer

UT Southwestern treats breast-cancer patient with Accuray CyberKnife System

New review: Multiple interventions might enable work-related outcomes among cancer survivors

CTI's fourth quarter net loss increases to $34.1 million

Diagnosis of breast cancer in women over 70 leads to lower survival

Genetic proof for anti-cancer properties of antioxidants and autophagy inhibitors

Study: Overexpression of EZH2 protein promotes breast cancer progression

Forensics and toxicology - Industry Focus eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Breast Cancer News and Research

Latest Breast Cancer News and Research

Forensics and toxicology - Industry Focus eBook eBook

Unlocking live single-cell functional insights

Fluidics in Modern Healthcare & Medical Device Innovation

How microRNA is transforming science: From discovery to diagnostics

Newsletters you may be interested in